Press release
Precision Oncology Market Likely to Reach USD 317.5 Billion by 2035
Precision Oncology Market Likely to Reach USD 317.5 Billion by 2035
MarketGenics, a leading market intelligence and consulting company, today announced its latest research report on the global precision oncology market, highlighting how rapid advances in genomics, AI-driven profiling, and targeted therapies are reshaping cancer care.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/precision-oncology-market-55206
The study underscores the integration of multi-omics, AI-powered clinical decision support, and tumor-agnostic therapies as the pivotal forces driving growth and shaping treatment personalization across global cancer care systems.
Market Structure & Outlook
The global precision oncology market is valued at USD 139.4 Billion in 2025 and is projected to reach USD 317.5 Billion by 2035, expanding at a CAGR of 7.8%. Growth will generate a total forecasting opportunity worth USD 178.1 Billion during the period.
Key growth drivers include:
Genomics & Sequencing (NGS): Cornerstone of oncology, enabling rapid and cost-efficient tumor profiling (~44% market share in 2025).
AI in Genomics: Accelerating clinical decision-making, as seen with Tempus Edge (launched April 2025), cutting time-to-therapy by ~40%.
Targeted Therapies & ADCs: FDA approvals like Datopotamab Deruxtecan (AstraZeneca/Daiichi Sankyo) advancing biomarker-guided oncology pipelines.
Tumor-Agnostic Therapies: Expanding patient eligibility, boosting drug development pathways.
Recent Developments & Strategic Moves
Thermo Fisher Scientific (April 2025) - Launched Oncomine Comprehensive Multi-Omics Assay, integrating DNA, RNA, and protein profiling for deeper tumor insights.
Licensing Deal (June 2025) - A $750M molecular glue degrader therapy agreement targeting CDK2 in solid tumors.
FDA Approval (June 2025) - Datroway approved in NSCLC, strengthening the biomarker-driven ADC pipeline.
Illumina (2025) - NovaSeq X Plus sequencing platform introduced with 30% lower cost and turnaround time.
To know more about the Precision Oncology Market - Download our Sample Report: https://marketgenics.co/download-report-sample/precision-oncology-market-55206
Drivers, Restraints, and Opportunities
Drivers - Rising adoption of NGS, biomarker-based therapies, and AI platforms enhancing clinical outcomes.
Restraints - High cost of multi-gene panels ($3,000-$5,000) and limited reimbursement frameworks in Europe and emerging markets.
Opportunities - Tumor-agnostic drugs, liquid biopsy adoption, and AI-supported companion diagnostics for therapy validation.
Key Trends
Rise of Multi-Omics - Integrated genomics, transcriptomics, proteomics, and metabolomics provide deeper insights into tumor evolution.
AI Integration - Platforms like Tempus Edge simplify noisy genomic datasets, democratizing adoption in community health systems.
Liquid Biopsy Momentum - Guardant360 CDx adoption expanding for non-invasive tumor profiling.
Regional Analysis
North America - Largest market (driven by Cancer Moonshot initiatives, reimbursement support, and strong R&D infrastructure). Illumina's TruSight Oncology FDA clearance (2024) boosted adoption of multi-gene diagnostics.
Europe - Early adoption in Germany and France, though reimbursement delays restrict rapid uptake.
Asia Pacific - Rapid adoption of sequencing and targeted therapies in China, Japan, and India; policy initiatives driving integration into national cancer programs.
Middle East & Africa - Growth supported by pilot precision oncology programs and genomic medicine partnerships.
South America - Increasing biomarker testing adoption as regional healthcare digitization accelerates.
Get a preview of our Precision Oncology Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and patient behavior trends: https://marketgenics.co/playbook/precision-oncology-market-55206
Competitive Landscape
The global precision oncology market is moderately fragmented with the top five players holding ~42% share in 2025.
Tier 1 Leaders - Roche, AstraZeneca, Novartis, Pfizer, Illumina.
Tier 2 Innovators - Guardant Health, Foundation Medicine, Qiagen, Agilent Technologies.
Tier 3 Specialists - Natera, Myriad Genetics, Invitae, Caris Life Sciences.
Key Companies: Illumina Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Guardant Health, Foundation Medicine, Qiagen, Natera, Novartis, AstraZeneca, Pfizer, Myriad Genetics, Caris Life Sciences, and others.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Precision Oncology Market Likely to Reach USD 317.5 Billion by 2035 here
News-ID: 4185970 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
Plant-based Snacks Market Likely to Surpass USD 92.4 Bn by 2035 | Biena Snacks, …
Global Plant-based Snacks Market Likely to Surpass USD 92.4 Bn by 2035.
A comprehensive study exploring emerging opportunities in, "Plant-based Snacks Market Size, Share, Growth Opportunity Analysis Report by Product Type (Fruit & Nut Snacks, Cereal/Grain-Based Snacks, Vegetable-Based Snacks, Legume-Based Snacks, Meat Alternative Snacks, Dairy Alternative Snacks, Snack Bars, Baked Goods and Others), Ingredient Type, Category, Distribution Channel, End User/ Consumer Group and Geography (North America, Europe, Asia Pacific, Middle East,…
Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott Laboratories, Clif …
A significant study discovering the market avenues on, "Protein Bar Market Size, Share, Growth Opportunity Analysis Report by Type (Snack Bars, Meal-Replacement Bars, Energy Bars, Low-Carb Bars and Others), Source, Protein Content, Flavor, Functionality, End-Use, Distribution Channel, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A holistic view of the market pathways in the protein bar market…
Protein Labeling Market Forecast 2035 | Key Driver, Restraint, and Growth Opport …
Global Protein Labeling Market Forecast 2035
According to the report, the global protein labeling market is likely to grow from USD 2.7 Billion in 2025 to USD 7.2 Billion in 2035 at a highest CAGR of 9.2% during the time period. The world protein labelling market is very dynamic and developing with the growth in proteomics studies, growing need of customized medicine and technological improvement in labeling technology.
Recently, Thermo Fisher Scientific…
Ready-to-Eat Food Market Forecast 2035 | Key Driver, Restraint, and Growth Oppor …
Ready-to-Eat Food Market Forecast 2035
According to the report, the global ready-to-eat food market is likely to grow from USD 167.9 billion in 2025 to USD 359.9 billion in 2035 at a moderate CAGR of 7.2% during the time period. The global RTE food market is seeing sustained growth on account of the evolving consumer lifestyles characterized by search for time, working couples, and urbanization.
The growing single-serve packaging of fine frozen…
More Releases for Oncology
Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031"
The global Precision Oncology market is estimated to reach over USD…
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The veterinary oncology market size…
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular Carcinoma Pipeline…
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost…
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview:
According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,…
